Life Sciences, Exits


Mpathy Medical was sold to Coloplast, a Danish company listed in Copenhagen, in November 2010. The original investment was made by Archangels in 2003.

Mpathy Medical is a medical device company that developed and brought to market a range of surgical solutions used to restore pelvic health to women. Mpathy Medical’s core product lines – Restorelle®, Omnisure™, and Minitape® – are used by surgeons specialising in urogynecology, gynecology and urology in the treatment of female stress urinary incontinence (SUI) and pelvic organ prolapse (POP).

Mpathy Medical supplies the only mesh surgical solutions designed specifically for the female anatomy. The mesh – branded Smartmesh® – is a physiologically compatible, ultra lightweight polypropylene mesh which encourages superior collagen growth and works in concert with the patient’s own natural tissue for optimum safety and results.

Year of exit


Seeking investment?

Our team is always actively seeking new investment opportunities. They review circa 200 business plans each year.

Become a member

Our members are genuinely motivated to give something back and build great businesses in Scotland, as well as making a financial return.

We use cookies to give you the best experience. Cookie Policy

Preloader image